Syneos Health Introduces FSP 360


Applied Clinical Trials

Syneos Health, the fully integrated biopharmaceutical solutions organization, introduced FSP 360, an evolved FSP model that provides access to the industry’s to a broad range of traditional and non-traditional FSP capabilities.

“As customers look to consolidate outsourced clinical solutions, traditional static FSP models no longer meet their unique scientific and operational demands,” said Paul Colvin, President, Syneos Health Clinical Solutions.

FSP 360 provides a range of capabilities through combining traditional service functions including monitoring, project management, safety/pharmacovigilance and data services, with non-traditional capabilities including investigator payments, eTMF, site contracts, feasibility and study start up. Engagements are scalable based on where a customer is in their outsourcing evolution.

To learn more

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.